Law Offices of Thomas J. Lamb

  • Asbestos & Mesothelioma
  • Benzene Diseases
  • Camp Lejeune Cases
  • Drug Injury
  • Free Case Evaluation
  • About Us

Tasigna Drug Injury Lawsuits Federal Court MDL Consolidation Order

August 24, 2021 By Law Offices of Thomas J. Lamb, P.A.

There is a newly created Tasigna multi-district litigation (MDL) for those Tasigna drug injury lawsuits filed in the federal court system.  We get some of the reasoning for this consolidation of Tasigna side effects cases from the August 10, 2021, JPML Transfer Order issued for IN RE: TASIGNA (NILOTINIB) PRODUCTS LIABILITY LITIGATION, MDL No. … [Read more...]

Filed Under: Unsafe Drugs Tagged With: Amputations, Aneurysms, Brain Aneurysm, Cerebrovascular Accidents (CVA), chronic kidney disease, Deep Vein Thrombosis (DVT), Heart Attacks, ischemic cerebrovascular disease, ischemic heart disease, Kidney Failure, Myocardial Infarctions (MI), peripheral arterial disease (PAD), peripheral arterial occlusive disease (PAOD), Pulmonary Embolism (PE), Renal Failure, Strokes, Tasigna

Farxiga And Jardiance Have Two-Time Increased Risk For Amputations

November 23, 2018 By Law Offices of Thomas J. Lamb, P.A.

Patients using the diabetes drugs Farxiga and Jardiance had twice the risk for lower limb amputations relative to certain other diabetes medicines, according to a new observational study published in November 2018 by The BMJ medical journal in. However, in the US only a third diabetes drugs in the sodium-glucose cotransporter 2 (SGLT2) … [Read more...]

Filed Under: Unsafe Drugs Tagged With: Amputations, diabetes drugs, drug injury, Farxiga, Invokamet, Invokana, Jardiance

Lower Limbs Amputations Are SGLT-2 Inhibitors Drug-Class Side Effects

October 18, 2018 By Law Offices of Thomas J. Lamb, P.A.

New medical evidence indicates that lower limbs amputations may be a “drug-class” side effect for all of the sodium-glucose cotransporter 2 (SGLT-2) inhibitor diabetes drugs which have been approved by the FDA to date. We get the following explanation of this increased risk of toe, foot, or leg amputations for Jardiance and Farxiga as well as … [Read more...]

Filed Under: Unsafe Drugs Tagged With: Amputations, Farxiga, Glyxambi, Invokamet, Invokana, Jardiance, Leg Amputation, Toes Amputation

Increased Risks Of Lower-Limb Amputations For Farxiga And Jardiance

September 5, 2018 By Law Offices of Thomas J. Lamb, P.A.

During late August a presentation at the 2018 European Society of Cardiology Congress in Munich, Germany included evidence that the SGLT-2 inhibitors Invokana, Jardiance, and Farxiga all are associated with twofold increases for lower-limb amputations when compared to GLP-1 receptor agonists diabetes drugs. An August 25, 2018 Healio.com article, … [Read more...]

Filed Under: Uncategorized, Unsafe Drugs Tagged With: Amputations, diabetes drugs, drug injury, Farxiga, Invokana, Jardiance

Invokana, Jardiance, And Farxiga Have Increased Risks Of Amputations

August 16, 2018 By Law Offices of Thomas J. Lamb, P.A.

Sodium-glucose cotransporter 2 inhibitors (SGLT-2 inhibitors) such as Invokana, Jardiance, and Farxiga have a higher risk of leg, feet, and toe amputations drug-class side effect when compared to older diabetes drugs such as sulfonylureas, metformin, and thiazolidinediones. This finding was reported in the article “Association Between … [Read more...]

Filed Under: Unsafe Drugs Tagged With: Amputations, Farxiga, Glyxambi, Invokamet, Invokana, Jardiance, Qtern, Segluromet, Steglatro, Steglujan, Synjardy, Xigduo

Jardiance – Lower Limb Amputations Drug Safety Issue Remains Uncertain

December 4, 2017 By Law Offices of Thomas J. Lamb, P.A.

It appears there needs to more medical research done on the risk of lower limb amputations for patients who use the increasing popular diabetes medicines in the sodium glucose cotransporter 2 (SGLT2) inhibitor class, such as canagliflozin (Invokana / Invokamet), empagliflozin (Jardiance / Glyxambi / Synjardy), and dapagliflozin (Farxiga / Xigduo / … [Read more...]

Filed Under: Unsafe Drugs Tagged With: Amputations, Farxiga, Foot Amputation, Glyxambi, Invokamet, Invokana, Jardiance, Leg Amputation, lower limb amputations, Qtern, Synjardy, Toes Amputation

“Dear Doctor” Letter About Invokana And Amputations Was Sent In Canada

September 12, 2017 By Law Offices of Thomas J. Lamb, P.A.

In September 2017 Health Canada required Janssen, the drug company responsible for Invokana and Invokamet, to send a Dear Healthcare Professional Letter — commonly referred to as a “Dear Doctor” letter — about the lower limb amputations side effect. Here are some of the points presented in this September 2017 Janssen letter to Canadian … [Read more...]

Filed Under: Unsafe Drugs Tagged With: Amputations, foot amputations, Invokamet, Invokana, leg amputations, lower limb amputations, toe amputations

Invokana Gets “Black-Box Warning” For Risk Of Leg And Foot Amputations

August 1, 2017 By Law Offices of Thomas J. Lamb, P.A.

In the final week of July 2017, the FDA issued a notification that it had approved a revised drug label for Invokana and Invokamet, as well as a revised Medication Guide for these two diabetes drugs from Janssen Pharmaceuticals. From the most recent drug label, or Full Prescribing Information, for Invokana (accessed 7/27/17), here is the text of … [Read more...]

Filed Under: Unsafe Drugs Tagged With: Amputations, FDA drug label warnings, foot amputations, Invokamet, Invokana, leg amputations, toe amputations

Can SGLT-2 Inhibitor Diabetes Drugs Increase Your Risk of Stroke?

June 21, 2017 By Law Offices of Thomas J. Lamb, P.A.

While we have frequently discussed DKA, kidney damage, and amputations as possible side effects of diabetes drugs in the SGLT-2 inhibitors class -- such as Farxiga, Invokana, Jardiance -- strokes and thromboembolic events are also considered potential harmful effects of these drugs. Based on FAERS reports received during the second quarter of … [Read more...]

Filed Under: Unsafe Drugs Tagged With: Acute Kidney Injury, Amputations, antidiabetic drugs, canagliflozin, canagliflozin/metformin HCl, causes of stroke, dapagliflozin, dapagliflozin/metformin HCl, Deep Vein Thrombosis, diabetes drugs, diabetic ketoacidosis, DKA, drug injury lawsuits, drug side effects, DVT, empagliflozin, empagliflozin/linagliptin, empagliflozin/metformin HCl, Farxiga, FDA, FDA FAERS reports, Glyxambi, Invokamet, Invokana, Jardiance, Kidney Damage, Kidney Failure, lower limb amputations, PE, Pulmonary Embolism, SGLT-2 inhibitors, Stroke, Synjardy, thromboembolic events, Xigduo, xigduo xr

Risk of Lower Limb Amputations Doubled with Invokana and Invokamet Use

May 17, 2017 By Law Offices of Thomas J. Lamb, P.A.

As of yesterday, May 16, 2017, the FDA issued a Drug Safety Communication regarding an increased risk of leg and foot amputations due to use of popular diabetes drugs Invokana, Invokamet, and Invokamet XR, which contain canagliflozin. These drugs belong to the sodium glucose cotransporter 2 (SGLT2) inhibitor class, and are the subjects of … [Read more...]

Filed Under: Unsafe Drugs Tagged With: Amputations, canagliflozin, dapagliflozin, drug injury, EMA, empagliflozin, Farxiga, FDA, foot amputations, Invokamet, Invokana, Jardiance, leg amputations, sglt2 inhibitors, side effects, toe amputations, Xigduo, xigduo xr

  • 1
  • 2
  • Next Page »

Find What You Want Here

Get Free Case Evaluation

We encourage you to submit an online Case Evaluation Form – it is confidential and there is no obligation.

Or call our toll-free number, 800-426-9535, to speak directly to attorney Tom Lamb about your possible case.

Feel Free To Contact Us

Quick Contact Form
 
Send an Email to Tom Lamb

(800) 426-9535

Main Navigation Menu

  • About Our Firm
  • Asbestos-Mesothelioma Cases
  • Benzene Disease Claims
  • PFAS Firefighter Gear Lawsuits
  • Camp Lejeune Cases
  • GenX Water Cancer Cases
  • Drug Injury Lawsuits
  • Breast Implant Cancer Cases
  • Philips Breathing Devices Cases
  • Case Evaluation Menu
  • Quick Contact Form
  • Frequently Asked Questions
  • Medical Records Charges
  • Collection of Articles
  • Sitemap

Lamb Law Office Newsletter

Lamb Law Office Newsletter provides periodic updates about some of the cases that we are working on for clients, as well as an information resource you might find helpful.

Subscribe using Form below.

Subscription Form

* indicates required

Our Other Websites

Drug Injury Law
Drug Injury Watch
Drug Safety Developments
Asbestos & Mesothelioma

Contact Information

Law Offices of Thomas J. Lamb, P.A.
1908 Eastwood Road, Suite 225
Wilmington, North Carolina 28403
910-256-2971 | 800-426-9535
TJL@LambLawOffice.com

  • Home
  • Frequently Asked Questions
  • Disclaimer and Copyright Notices

Copyright © 2023 · Law Offices of Thomas J. Lamb, P.A.